Simplify Logo

Full-Time

Staff Scientist

Machine Learning and Cheminformatics

Confirmed live in the last 24 hours

Atomwise

Atomwise

51-200 employees

AI-driven drug discovery platform

Hardware
AI & Machine Learning
Biotechnology
Healthcare

Compensation Overview

$210k - $250kAnnually

Senior, Expert

Remote in USA

Category
Bioinformatics
Computational Biology
Genomics
Biology & Biotech
Required Skills
Python
R
Data Analysis
Requirements
  • Ph.D in Computer Science, Statistics, Cheminformatics, Bioinformatics, Computational Biology, or a related discipline
  • 5+ years experience in methods and algorithm development leveraging biochemical data
  • Experience working with large-scale datasets, performing efficient data curation, and working effectively with datasets that are complicated, messy, or incomplete
  • Experience in virtual screening, QSAR, molecular docking, pharmacophore modeling, or other molecular modeling modalities
  • Sound knowledge of statistics, data analytics, and data visualization
  • Strong coding skills in at least one high-level programming language (Python, R, Java, C++, etc) and cheminformatics toolkits (e.g., RDKit, DeepChem, etc)
  • Strong familiarity with Linux command-line environment
  • Proactive team player, effective communicator, and creative problem solver
Responsibilities
  • Design, develop, train, and benchmark large generative and predictive models for bioactivity prediction and chemical design, in collaboration with our machine learning team
  • Develop and maintain data pipelines for processing large-scale datasets in cheminformatics and structural biology
  • Develop methods, datasets, and tools for benchmarking and validation of ML models
  • Collaborate with CADD scientists, medicinal chemists, biologists, and other cross-functional roles within project teams to support and facilitate platform application to specific projects
  • Communicate cross-functionally with a wide range of company stakeholders
  • Contribute to our codebase with well-designed and readable Python code
  • Contribute to a collaborative and inclusive team culture

Atomwise operates in the pharmaceutical industry by using artificial intelligence (AI) to enhance drug discovery. The main product is an AI engine that employs machine learning and convolutional neural networks to analyze extensive chemical libraries. This technology allows Atomwise to identify new small molecule medicines more efficiently than traditional methods. The company primarily serves clients in healthcare and pharmaceuticals, aiming to streamline the drug discovery process. Atomwise's business model involves developing and co-developing drug candidates, which are then sold to pharmaceutical companies or healthcare providers. What sets Atomwise apart from competitors is its integration of AI and machine learning, which accelerates the creation of effective medicines while reducing costs and time. The ultimate goal of Atomwise is to improve patient outcomes by delivering better treatments more quickly.

Company Stage

Series B

Total Funding

$176.6M

Headquarters

San Francisco, California

Founded

2012

Growth & Insights
Headcount

6 month growth

-27%

1 year growth

0%

2 year growth

-27%
Simplify Jobs

Simplify's Take

What believers are saying

  • Atomwise's recent $175 million venture capital funding round provides substantial financial backing for continued innovation and growth.
  • The appointment of industry veterans like Gavin Hirst as Chief Scientific Officer and Neely Mozaffarian as Chief Medical Officer strengthens the company's leadership team and expertise.
  • Successful partnerships, such as with Hansoh Pharma, highlight Atomwise's ability to collaborate effectively and achieve significant milestones in drug discovery.

What critics are saying

  • The competitive landscape of AI-driven drug discovery is rapidly evolving, requiring Atomwise to continuously innovate to maintain its edge.
  • High expectations for AI in drug discovery could lead to potential overpromising and underdelivering, impacting the company's reputation and client trust.

What makes Atomwise unique

  • Atomwise leverages AI and machine learning to significantly reduce the time and cost of drug discovery, unlike traditional methods that are more time-consuming and expensive.
  • Their AI engine, AtomNet, has demonstrated a higher hit success rate and the ability to discover structurally novel chemical matter, setting it apart from conventional high-throughput screening (HTS) methods.
  • The company's focus on developing and co-developing pipeline assets backed by investors provides a unique business model that aligns financial incentives with successful drug discovery.

Benefits

Medical, dental, & vision

FSA

401k

Parental leave

Commuter benefits

Professional development